204 related articles for article (PubMed ID: 31298410)
1. MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.
Wang J; Guo J; Fan H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5168-5175. PubMed ID: 31298410
[TBL] [Abstract][Full Text] [Related]
2. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
3. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696
[TBL] [Abstract][Full Text] [Related]
4. MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.
Zhou QY; Peng PL; Xu YH
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9427-9435. PubMed ID: 31773681
[TBL] [Abstract][Full Text] [Related]
5. MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.
Xie J; Wen JT; Xue XJ; Zhang KP; Wang XZ; Cheng HH
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1914-1921. PubMed ID: 29687843
[TBL] [Abstract][Full Text] [Related]
6. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
7. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
Li M; Zheng R; Yuan FL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5987-5993. PubMed ID: 30280781
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
[TBL] [Abstract][Full Text] [Related]
9. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
10. MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells.
Du SL; Xu LY; Gao P; Liu QS; Lu FF; Mo ZH; Fan ZZ; Cheng XL; Dong ZH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8833-8840. PubMed ID: 31696470
[TBL] [Abstract][Full Text] [Related]
11. MiR-223 regulates CDDP resistance in pancreatic cancer via targeting FoxO3a.
Huang R; Song X; Wang CM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7892-7898. PubMed ID: 31599414
[TBL] [Abstract][Full Text] [Related]
12. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
Han GY; Cui JH; Liang S; Li HL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
[TBL] [Abstract][Full Text] [Related]
13. MiR-324/SOCS3 Axis Protects Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury and Regulates Myocardial Ischemia via TNF/NF-κB Signaling Pathway.
Han X; Chen X; Han J; Zhong Y; Li Q; An Y
Int Heart J; 2020 Nov; 61(6):1258-1269. PubMed ID: 33191336
[TBL] [Abstract][Full Text] [Related]
14. Expression of miR-29 and STAT3 in osteosarcoma and its effect on proliferation regulation of osteosarcoma cells.
Li MH; Wu ZY; Wang Y; Chen FZ; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7275-7282. PubMed ID: 31539114
[TBL] [Abstract][Full Text] [Related]
15. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
[TBL] [Abstract][Full Text] [Related]
16. MiR-142 inhibits lung cancer cell proliferation and promotes apoptosis by targeting XIAP.
Wu XB; Li QH; Zhang N; Li M; Li K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7430-7437. PubMed ID: 31539130
[TBL] [Abstract][Full Text] [Related]
17. MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer.
Yang J; Zhu H; Jin Y; Song Y
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4493-4499. PubMed ID: 30058687
[TBL] [Abstract][Full Text] [Related]
18. MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
Wei H; He WR; Chen KM; Wang XW; Yi CJ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5640-5647. PubMed ID: 31298355
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic β cells via the inhibition of SOCS3.
Li Y; Luo T; Wang L; Wu J; Guo S
Int J Mol Med; 2016 Nov; 38(5):1515-1524. PubMed ID: 27666763
[TBL] [Abstract][Full Text] [Related]
20. High-concentration atropine induces corneal epithelial cell apoptosis via miR-30c-1/SOCS3.
Chen XJ; Hu P; Yi S
Kaohsiung J Med Sci; 2022 Nov; 38(11):1113-1122. PubMed ID: 36156413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]